Cargando…

[(18)F]FE-PE2I DAT correlates with Parkinson’s disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study

BACKGROUND: Correlations between dopamine transporter (DAT) availability and Parkinson’s disease (PD) motor symptoms vary depending on the imaging modality, choice of regions of interest and clinical measures. We aimed to validate the PET radioligand [(18)F]FE-PE2I as a clinical biomarker in PD, hyp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kerstens, Vera S., Fazio, Patrik, Sundgren, Mathias, Halldin, Christer, Svenningsson, Per, Varrone, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076455/ https://www.ncbi.nlm.nih.gov/pubmed/37017878 http://dx.doi.org/10.1186/s13550-023-00974-7

Ejemplares similares

Longitudinal DAT changes measured with [(18)F]FE-PE2I PET in patients with Parkinson’s disease; a validation study
por: Kerstens, V.S., et al.
Publicado: (2023)

Reliability of dopamine transporter PET measurements with [(18)F]FE-PE2I in patients with Parkinson’s disease
por: Kerstens, Vera S., et al.
Publicado: (2020)

Simplified quantification of [(18)F]FE-PE2I PET in Parkinson’s disease: Discriminative power, test–retest reliability and longitudinal validity during early peak and late pseudo-equilibrium
por: Brumberg, Joachim, et al.
Publicado: (2020)

Microsome Mediated in Vitro Metabolism: A Convenient Method for the Preparation of the PET Radioligand Metabolite [(18)F]FE-PE2I-OH for Translational Dopamine Transporter Imaging
por: Schou, Magnus, et al.
Publicado: (2023)

High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort
por: Fazio, Patrik, et al.
Publicado: (2020)

PET Imaging of VMAT2 with the Novel Radioligand [(18)F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [(11)C]DTBZ and [(18)F]FE-DTBZ
por: Nag, Sangram, et al.
Publicado: (2021)

Quantitative Analysis of Bradykinesia and Rigidity in Parkinson’s Disease
por: di Biase, Lazzaro, et al.
Publicado: (2018)

PET imaging of [(11)C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
por: Varnäs, Katarina, et al.
Publicado: (2018)

Novel Imaging Biomarkers for Huntington’s Disease and Other Hereditary Choreas
por: Fazio, Patrik, et al.
Publicado: (2018)

Beta band stability over time correlates with Parkinsonian rigidity and bradykinesia
por: Little, S., et al.
Publicado: (2012)

ABC transporter-dependent brain uptake of the 5-HT(1B) receptor radioligand [(11)C]AZ10419369: a comparative PET study in mouse, rat, and guinea pig
por: Tóth, Miklós, et al.
Publicado: (2014)

“In‐loop” carbonylation—A simplified method for carbon‐11 labelling of drugs and radioligands
por: Ferrat, Mélodie, et al.
Publicado: (2020)

PET Evaluation of the Novel F-18 Labeled Reversible Radioligand [(18)F]GEH200449 for Detection of Monoamine Oxidase-B in the Non-Human Primate Brain
por: Varnäs, Katarina, et al.
Publicado: (2023)

[(11)C]MADAM Used as a Model for Understanding the Radiometabolism of Diphenyl Sulfide Radioligands for Positron Emission Tomography (PET)
por: Gourand, Fabienne, et al.
Publicado: (2015)

Kinetic analysis and test-retest variability of the radioligand [(11)C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects
por: Jučaite, Aurelija, et al.
Publicado: (2012)

Effects of sevoflurane anaesthesia on radioligand binding to monoamine oxidase-B in vivo
por: Varnäs, Katarina, et al.
Publicado: (2021)

High-Cadence Cycling Promotes Sustained Improvement in Bradykinesia, Rigidity, and Mobility in Individuals with Mild-Moderate Parkinson's Disease
por: Ridgel, Angela L., et al.
Publicado: (2019)

Characterization of a Novel M4 PAM PET Radioligand [11C]PF06885190 in Nonhuman Primates (NHP)
por: Nag, Sangram, et al.
Publicado: (2023)

Assessing Bradykinesia in Parkinsonian Disorders
por: Pal, Gian, et al.
Publicado: (2013)

Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson’s Disease: A 7 Tesla Imaging Study
por: Poston, Kathleen L., et al.
Publicado: (2020)

Synthesis and Autoradiography of Novel F-18 Labeled Reversible Radioligands for Detection of Monoamine Oxidase B
por: Nag, Sangram, et al.
Publicado: (2020)

Potential for imaging the high-affinity state of the 5-HT(1B) receptor: a comparison of three PET radioligands with differing intrinsic activity
por: Lindberg, Anton, et al.
Publicado: (2019)

Synthesis, Biodistribution, and Radiation Dosimetry of a Novel mGluR5 Radioligand: (18)F-AZD9272
por: Nag, Sangram, et al.
Publicado: (2020)

Characterization of [(11)C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain
por: Yang, Kai-Chun, et al.
Publicado: (2016)

A randomized placebo-controlled PET study of ketamine´s effect on serotonin(1B) receptor binding in patients with SSRI-resistant depression
por: Tiger, Mikael, et al.
Publicado: (2020)

Sertraline treatment influences [(18)F]FE-PE2I PET imaging for Parkinsonism
por: Justesen, Thomas E. H., et al.
Publicado: (2023)

Quantification of the purinergic P2X(7) receptor with [(11)C]SMW139 improves through correction for brain-penetrating radiometabolites
por: Brumberg, Joachim, et al.
Publicado: (2022)

Technologies Assessing Limb Bradykinesia in Parkinson’s Disease
por: Hasan, Hasan, et al.
Publicado: (2017)

Dopamine transporter imaging with [(18)F]FE-PE2I PET and [(123)I]FP-CIT SPECT—a clinical comparison
por: Jakobson Mo, Susanna, et al.
Publicado: (2018)

Revisiting the Logan plot to account for non-negligible blood volume in brain tissue
por: Schain, Martin, et al.
Publicado: (2017)

Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease
por: Sundgren, Mathias, et al.
Publicado: (2021)

Mirror Visual Feedback to Improve Bradykinesia in Parkinson's Disease
por: Bonassi, Gaia, et al.
Publicado: (2016)

Haloperidol: Bradykinesia and tremor of upper limb: case report
Publicado: (2021)

The association of DAT gene methylation with striatal DAT availability in healthy subjects
por: Pak, Kyoungjune, et al.
Publicado: (2021)

Test of DAT-DISP
Publicado: (1980)

Standardized Handwriting to Assess Bradykinesia, Micrographia and Tremor in Parkinson's Disease
por: Smits, Esther J., et al.
Publicado: (2014)

Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
por: Kojovic, Maja, et al.
Publicado: (2014)

The Effect of Motivation on Movement: A Study of Bradykinesia in Parkinson’s Disease
por: Shiner, Tamara, et al.
Publicado: (2012)

Quantitative assessment of parkinsonian bradykinesia based on an inertial measurement unit
por: Dai, Houde, et al.
Publicado: (2015)

An Expert System for Quantification of Bradykinesia Based on Wearable Inertial Sensors
por: Bobić, Vladislava, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bha6oct7t00avrl6qideebk71a